MB, Levis & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.2K | Buy |
1,581
+395
| +33% | +$18.3K | 0.03% | 106 |
|
|
2025
Q1 | $72.4K | Buy |
1,186
+8
| +0.7% | +$488 | 0.03% | 104 |
|
|
2024
Q4 | $66.6K | Buy |
1,178
+8
| +0.7% | +$453 | 0.03% | 105 |
|
|
2024
Q3 | $60.5K | Buy |
1,170
+10
| +0.9% | +$517 | 0.03% | 111 |
|
|
2024
Q2 | $48.2K | Buy |
1,160
+10
| +0.9% | +$415 | 0.03% | 116 |
|
|
2024
Q1 | $62.4K | Buy |
1,150
+9
| +0.8% | +$488 | 0.03% | 107 |
|
|
2023
Q4 | $58.6K | Buy |
1,141
+8
| +0.7% | +$411 | 0.03% | 107 |
|
|
2023
Q3 | $65.8K | Buy |
1,133
+7
| +0.6% | +$406 | 0.04% | 96 |
|
|
2023
Q2 | $72K | Buy |
1,126
+6
| +0.5% | +$384 | 0.05% | 95 |
|
|
2023
Q1 | $77.6K | Buy |
1,120
+1
| +0.1% | +$69 | 0.05% | 90 |
|
|
2022
Q4 | $80.5K | Buy |
+1,119
| New | +$80.5K | 0.06% | 85 |
|